Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Big Data in Pharma:
Current & Future Trends for Big Data Utilization
Across Medical, Commercial and HEOR Functions
Best Pr...
2
Table of Contents
I. Executive Summary pp. 4-12
 Research Overview pp. 4
 Universe of Learning pp. 5-6
 Big Data Team...
Best Practices, LLC, conducted a customized study – with responses segmented by medical,
commercial and HEOR functions - t...
Benchmark Class:
Eighteen Companies Participated in the Benchmark Study
22 analytics, marketing and HEOR leaders from 18 d...
Copyright © Best Practices , LLC
5
Directors Make Up Most Participants; 81% Based in U.S.
Director
57%
Lead
9%
VP
19%
Mana...
Copyright © Best Practices , LLC
6
Analytics
Team
Big Data
Function
Understanding Big Data Use in Medical, HEOR & Commerci...
Copyright © Best Practices , LLC
7
Quantitative Findings: Big Data Teams and Data Producers
For the medical, commercial an...
Copyright © Best Practices , LLC
8
Big Data cuts across different functional groups – IT, Commercial, Medical – and each g...
9
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Point of Sale (POS) Claims Electronic Health
Records (EHR) /
Electronic Medi...
10
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Impact of Online Data (HEOR)
Highly impactful Somewhat impactful Not impact...
11
Medical Leaders Describe Analytics As Centralized
Medical leaders were the most likely to describe their analytics effo...
12
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Partnership Value (Medical)
Highly impactful Somewhat impactful Not impactf...
13
No Obvious Trends Between Functions
Certain functions do not clearly outpace the others.
Q: Types of Big Data projects ...
Copyright © Best Practices , LLC
14
Best Practices, LLC is a research and consulting firm that conducts work
based on the ...
Upcoming SlideShare
Loading in …5
×

Big Data Trends & Utilization Across Medical, Commercial & HEOR Functions

240 views

Published on

Big Data/Real World Analytics can be the catalyst for dramatic change in U.S. healthcare. Big Data informs many commercial, medical and HEOR decisions. On an average, Pharma Companies use 35-50% of analytics techniques to support commercial, medical and HEOR decisions. Data acquisition and infrastructure represent a majority of spending for Big Data. Data management cost-sharing
across functions could drive savings & boost effectiveness. Howwever, the pharmaceutical industry is still in the early stages of utilizing large data sets from different sources to inform critical aspects of medical, commercial and HEOR operations.

Best Practices, LLC published this study by engaging 22 leaders from 18 pharmaceutical companies through a benchmarking survey. This study aims to produce reliable industry metrics on current and future trends for Big Data utilization across medical, commercial and HEOR groups. A majority of study participants think partnerships with health plans/payers and data aggregators have a high impact on Big Data projects and programs. The respondents said about 20% of data is sourced from partnerships.

Download Full Report: http://bit.ly/2cTW4wR

Published in: Data & Analytics
  • Be the first to comment

  • Be the first to like this

Big Data Trends & Utilization Across Medical, Commercial & HEOR Functions

  1. 1. Big Data in Pharma: Current & Future Trends for Big Data Utilization Across Medical, Commercial and HEOR Functions Best Practices, LLC Strategic Benchmarking Research Study with Segmented Responses by Medical, Commercial and HEOR Functions
  2. 2. 2 Table of Contents I. Executive Summary pp. 4-12  Research Overview pp. 4  Universe of Learning pp. 5-6  Big Data Team Overview and Key Study Insights pp. 7-8  Quantitative Key Findings pp. 9-12 II. Defining Big Data pp. 13-20 III. Data Types / Sources by Medical, Commercial and HEOR Segments pp. 21-36 IV. Data Producers, Dissemination & Requestors by Medical, Commercial and HEOR Segments pp. 37-49 V. Centralization pp. 50-56 VI. Governance and Leadership pp. 57-87
  3. 3. Best Practices, LLC, conducted a customized study – with responses segmented by medical, commercial and HEOR functions - to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts medical, HEOR, and commercial operations in the U.S.  Best Practices, LLC engaged 22 leaders from 18 pharmaceutical companies through a benchmarking survey. There were multiple responses from 3 companies but they each represent a different functional area (medical, commercial, or HEOR).  Research analysts also conducted seven deep-dive executive interviews with selected benchmark participants. Research Goal Research Methodology  Produce reliable industry metrics on current and future trends for Big Data utilization across medical, commercial and HEOR groups. Topics Covered  Types of Big Data Projects Used to Support Medical, Commercial and HEOR Decisions  Big Data Capabilities and Governance  Types and Value of Data Used for Big Data Projects  Big Data Staffing and Budget Levels  Value Rating of Partnerships on Big Data Projects  Policies and Procedures Governing Big Data Activities  Investigate data types, data partnerships, and staffing/budget levels companies are using as they move to a more analytically based approach to commercial, HEOR & medical decisions. Research Overview Research Project Objectives & Methodology
  4. 4. Benchmark Class: Eighteen Companies Participated in the Benchmark Study 22 analytics, marketing and HEOR leaders from 18 different companies participated in this study. Participants were recruited because of their presumed investment in Big Data analytics. Three companies had multiple responses - each representing a different functional area (medical, commercial, or HEOR).
  5. 5. Copyright © Best Practices , LLC 5 Directors Make Up Most Participants; 81% Based in U.S. Director 57% Lead 9% VP 19% Manager 10% Statistician 5% Titles: Associate Director Global Market Research Director (5) Associate Director Executive Director Senior Scientific Analyst Vice President Global Forecasting Director Director, HEOR Associate Manager, clinical data Therapeutic Area Lead Vice President, HEOR (2) Global Brand Manager Associate Director, Forecasting Executive Director, Outcomes Research Statistician UK 5% U.S. 81% France 9% Spain 5% The benchmark class draws heavily on top-level personnel in analytics and HEOR programs. Though participants responsibilities sometimes covered broad geographic areas, 81% were personally located in the U.S.
  6. 6. Copyright © Best Practices , LLC 6 Analytics Team Big Data Function Understanding Big Data Use in Medical, HEOR & Commercial Decision-Making Big Data Questions • Medical • Commercial • HEOR Big Data Info Types • Electronic Health Records • Government Cost Data • Health Outcomes Big Data Projects • Value Proposition Development • Post-Launch Performance • Real World Studies Big Data Decisions • Go/No Clinical Decisions • ID Market Opportunities • Developing Economic Models/Assessments
  7. 7. Copyright © Best Practices , LLC 7 Quantitative Findings: Big Data Teams and Data Producers For the medical, commercial and HEOR segments, the following key Big Data team presence, data producers and analysis targets were observed in this study. Half of the study participants for both the medical and HEOR segments said they have a centralized/dedicated group (Big Data team or function) to support Big Data projects. For the commercial segment, 40% said they have a centralized/dedicated Big Data group. Only 5 of 36 types of Transactional, Reported, Online, Scientific and Machine- Generated data were rated highly valuable by a majority of study participants in each of the three segments (medical, commercial and HEOR). They were: Claims; EHR (Electronic Health Records); Health Outcomes (provider/payer reported); Real World Studies; and Registries. No types of Online or Machine- Generated data were rated highly valuable by a majority of any segment Internal Commercial, Medical and Development functions were rated by a majority of medical, commercial and HEOR respondents as the most impactful targets for data analysis presentations. A majority of each segment also said these internal groups were also the most frequent requestors of presentations. Only 5 of 36 Types of Data Rated as Highly Valuable Across all 3 Segments Majority of Each Segment Rate Internal Groups as Most Impactful Targets for Data Analysis Most Have Centralized or Dedicated Big Data Team or Function
  8. 8. Copyright © Best Practices , LLC 8 Big Data cuts across different functional groups – IT, Commercial, Medical – and each group has its own issues with how to utilize the potential inherent in large data sets from disparate sources. “The term Big Data is nebulous. Anyone you talk to, it means different things…are you coming from an IT perspective? Are you coming from a patient level data perspective? Are you coming from a digital perspective? I can get more tangible when I come from those angles because I have all these conversations internally and we're honestly on different pages what it means to them. “ - Director, Customer Data Big Data Means Different Things to Different People/Functions
  9. 9. 9 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Point of Sale (POS) Claims Electronic Health Records (EHR) / Electronic Medical Records (EMR) / HIE (Health Information Exchanges) ePrescription / pharmacy fulfillment Wholesalers / Group Purchasing Organizations (GPOs) Government (e.g., cost data) Credit card Impact of Transactional Data (Commercial) Highly impactful Somewhat impactful Not impactful Not used While a majority of commercial participants rated claims and Electronic Medical Records (EMR) as the most valuable types of transactional data for Big Data studies, 50 % also cited point of sale as highly impactful or valuable. N=12 Q: How impactful (or valuable) has each of the following types of transactional data sources proven to be? Transactional Data: Commercial Rates Claims, EMR Most Valuable
  10. 10. 10 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Impact of Online Data (HEOR) Highly impactful Somewhat impactful Not impactful Not used Online Data: HEOR Finds Online Information of Limited Impact Participants in HEOR roles – like their peers in Medical – didn’t give online data high impact ratings for using in Big Data studies. N=15 Q: How impactful (or valuable) has each of the following types of online data sources proven to be?
  11. 11. 11 Medical Leaders Describe Analytics As Centralized Medical leaders were the most likely to describe their analytics efforts as having centralized or dedicated personnel. N=12 Q: Do you have a centralized/ dedicated group of individuals to support Big Data projects? Yes 58% No 42% Dedicated Big Data Team (Medical)
  12. 12. 12 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Partnership Value (Medical) Highly impactful Somewhat impactful Not impactful Not used Medical: Health Plans/Payers, Aggregators and Health Systems Seen as Highly Impactful Partners Medical leaders were most likely to rate partnerships as highly valuable across all varieties of collaborations. Most popular were collaborations with payers and data aggregators. N=12 Q: Which of the following partners are most impactful/ valuable on Big Data programs and projects?
  13. 13. 13 No Obvious Trends Between Functions Certain functions do not clearly outpace the others. Q: Types of Big Data projects currently used to support these medical decisions: N=10,9,12 0% 10% 20% 30% 40% 50% 60% 70% Targets for Drug Development Other Drug Development Decisions % of Surveyed Techniques Employed in Decisions Medical Commercial HEOR
  14. 14. Copyright © Best Practices , LLC 14 Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics, and winning strategies of world-class companies. Best Practices, LLC 6350 Quadrangle Drive, Suite 200 Chapel Hill, NC 27517 www.best-in-class.com About Best Practices, LLC

×